Advertisement

Topics

Fusion Antibodies Ltd Company Profile

10:27 EST 19th December 2018 | BioPortfolio

Fusion, established in 2001 as a spin-out from Queen’s University Belfast, has won a host of awards for its leading-edge technology platform FET (Fusion Expression Technology). This enabling technology accelerates the validation of targets from DNA sequence through to recombinant protein expression. Fusion generates target specific antibodies from protein antigens with capability, through its antibody engineering know-how, to modify their characteristics to increase efficacy. These technologies and associated microbiological techniques, in addition to supporting Fusion’s own therapeutic and diagnostic R&D, are offered as a service to pharmaceutical, biopharmaceutical and academic researchers, allowing them to achieve their goals faster and more cost effectively. Fusion has expertise in producing specific antibodies for therapeutic, diagnostic and theranostic applications.

Location

PO Box 374
Belfast
Northern Ireland
BT1 2WD
United Kingdom

Contact

Phone: 44(0)28 9063 2639
Fax: 44(0)28 9063 2639
Email: info@fusionantibodies.com


News Articles [563 Associated News Articles listed on BioPortfolio]

Fusion Antibodies collab using AI to generate humanized antibodies

Fusion Antibodies signed an agreement with Analytics Engines to bring machine learning and AI to its humanization platform in an aim to bolster product quality and manufacturability.

Fusion Antibodies exploring AI use, driving up quality to compete with ‘pop up consultants’

Fusion Antibodies revenue grew 41% in FY2018, and while âpop up consultantsâ have created new competition, the CRO is differentiating itself by investing in its services and focusing on quality.

Is Fusion Antibodies the one-stop shop for Humanizing Antibodies?

Fusion Antibodies is a Contract Research Organisation (CRO) established in 2001. Offering a fee-for-service, royalty free, risk free development service from discovery right through to clinical studi...

Fusion Antibodies and Analytics Engines to Incorporate Artificial Intelligence into Its World ...

Fusion Antibodies plcDr. Paul Kerr, CEOEmail: paul.kerr@fusionantibodies.comWebsite: www.fusionantibodies.comAnalytics EnginesDr. Aislinn Rice, CEOEmail: a.rice@analyticsengines.comWebsi...

Fusion Antibodies and Analytics Engines to Incorporate Artificial Intelligence into Its World Class Antibody Humanization Service

Fusion Antibodies plc, experts in antibody engineering and Analytics Engines, an advanced data analytics company, have announced a strategic collaboration to incorporate machine l...

SNARE-mediated membrane fusion arrests at pore expansion to regulate the volume of an organelle

Constitutive membrane fusion within eukaryotic cells is thought to be controlled at its initial steps, membrane tethering and SNARE complex assembly, and to rapidly proceed from there to full fusion. ...

Vatics Standardizes on Synopsys' Fusion Technology for its Next-Generation Multimedia SoC Design

Fusion Technology enables Vatics to achieve highest design performance while eliminating ECO iterations on their 28-nm multimedia SoC design ECO Fusion delivers signoff accuracy during Read...

Neutrons produce first direct 3-D maps of water during cell membrane fusion

New 3-D maps of water distribution during cellular membrane fusion are accelerating scientific understanding of cell development, which could lead to new treatments for diseases associated with cell f...

PubMed Articles [1467 Associated PubMed Articles listed on BioPortfolio]

Hitting HIV's Harpoon.

The HIV-1 fusion peptide is a target for broadly neutralizing antibodies. In a recent issue of Nature Medicine, Xu et al. (2018) provide proof-of-concept that vaccination with fusion peptide followed...

Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV.

Eliciting broadly neutralizing antibodies (bnAbs) targeting envelope (Env) is a major goal of HIV vaccine development, but cross-clade breadth from immunization has only sporadically been observed. Re...

HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay.

Human Immunodeficiency Virus-1 (HIV-1) entry is dependent on the envelope glycoprotein (Env) that is present on the virion and facilitates fusion between the envelope and the cellular membrane. The pr...

Breast milk prefusion F IgG as a correlate of protection against respiratory syncytial virus acute respiratory illness.

Transplacental RSV antibody transfer has been characterized, but little is known about the protective effect of breast milk RSV-specific antibodies. Serum antibodies against the prefusion RSV fusion p...

Single-Molecule Analysis of a Viral Fusion Protein Illuminates a Fusion-Active Intermediate State.

The influenza virus hemagglutinin (HA) fusion glycoprotein mediates viral entry into host cells through its receptor binding and membrane fusion activities. In this issue of Cell, Das et al. use sing...

Clinical Trials [1951 Associated Clinical Trials listed on BioPortfolio]

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab in Treating Patients With Metastatic or Recurrent Urothelial Cancer That Is Refractory to Certain Chemotherapy Drugs

This phase II trial studies how well recombinant EphB4-HSA fusion protein and pembrolizumab work in treating patients with urothelial (bladder) cancer that has spread from the primary site...

Comparative Study Between Posterior Lumbar Interbody Fusion(PLIF) and Intertransverse Process Fusion in Treatment of Spodylolithesis

The first technique described for interbody fusion was the anterior lumbar interbody fusion (ALIF).(20) For this technique, the intervertebral disc is accessed through a retroperitoneal or...

A Prospective, 5-Year Global Study on MAST™ Minimally Invasive Fusion Procedures for the Treatment of the Degenerative Lumbar Spine

The purpose of this study is - to evaluate the effectiveness of MAST techniques for anterior/lateral and posterior approaches in patients with spondylolisthesis (≥ grade I). ...

Evaluation of Radiographic and Patient Outcomes Following Lumbar Spine Fusion Using Demineralized Bone Matrix (DBM) Mixed With Autograft

The purpose of this study is to compare Optecure™ as an autograft extender (treatment) to autograft alone (control) in patients undergoing 1 or 2 level fusion of the lumbar spine(one lev...

Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475

This phase IIa trial studies how well recombinant EphB4-HSA fusion protein and pembrolizumab work in treating patients with non-small cell lung cancer that has spread to other places in th...

Companies [646 Associated Companies listed on BioPortfolio]

Fusion Antibodies Ltd

Fusion, established in 2001 as a spin-out from Queen’s University Belfast, has won a host of awards for its leading-edge technology platform FET (Fusion Expression Technology). This enabling technol...

Practice Fusion Inc.

Practice Fusion addresses the complexities and critical needs of today's healthcare environments by providing a revolutionary free, web-based electronic health record (EHR) application and delivery mo...

Affinity Bioreagents Incorporated

Apoptosis Related Antibodies Bioactive Peptide Antibodies Chaperonin Antibodies Cytochrome P450 Antibodies Heat Shock Protein Antibodies Immunophilin Antibodies Ion Transport Protein Antibodies Lipid ...

Kareo

Practice Fusion provides a free, web-based Electronic Health Record (EHR) system to physicians. With charting, scheduling, e-prescribing, billing, lab integrations, unlimited support and a Personal He...

Fusion Advertising

Fusion Advertising is a boutique agency and creative factory based in Dallas, TX. Formed in 2004, Fusion blends key staff members from diverse creative, media, logistics, financial and entrepreneu...

More Information about "Fusion Antibodies Ltd" on BioPortfolio

We have published hundreds of Fusion Antibodies Ltd news stories on BioPortfolio along with dozens of Fusion Antibodies Ltd Clinical Trials and PubMed Articles about Fusion Antibodies Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fusion Antibodies Ltd Companies in our database. You can also find out about relevant Fusion Antibodies Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record